Market Research Logo

Biogen, Inc. - Strategy, SWOT and Corporate Finance Report

Biogen, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Biogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Biogen, Inc. (Biogen or 'the company') formerly known as Biogen Idec, is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of therapies in the areas of hematology, neurology and immunology. The company's key products include Tecfidera, Tysabri (natalizumab), Avonex (Interferon beta-1a) and Rituxan (rituximab). The company primarily operates in the US and Europe. Biogen is headquartered in Weston, Massachusetts, the US.

Scope

  • Detailed information on Biogen, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
  • Intelligence on Biogen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Biogen, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
  • Gain understanding of Biogen, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Biogen, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Biogen, Inc.'s business structure, strategy and prospects.


Company Snapshot
Biogen, Inc.: Company Overview
Biogen, Inc.: Overview and Key Facts
Biogen, Inc.: Overview
Biogen, Inc.: Key Facts
Biogen, Inc.: Key Employees
Biogen, Inc.: Key Employee Biographies
Biogen, Inc.: Major Products and Services
Biogen, Inc.: Company History
Biogen, Inc.: Management Statement
Biogen, Inc.: Locations and Subsidiaries
Biogen, Inc.: Key Competitors
Biogen, Inc.: Company Analysis
Biogen, Inc.: Business Description
Biogen, Inc.: SWOT Analysis
Biogen, Inc.: SWOT Overview
Biogen, Inc.: Strengths
Biogen, Inc.: Weaknesses
Biogen, Inc.: Opportunities
Biogen, Inc.: Threats
Biogen, Inc.: Corporate Financial Deals Activity
Biogen, Inc.: Financial Deals Overview
Biogen, Inc.: Targets and Partners
Biogen, Inc.: Top Deals 2014 - 2018YTD*
Biogen, Inc.: Advisors
Biogen, Inc.: Top Financial Advisors
Biogen, Inc.: Mergers and Acquisitions
Biogen, Inc.: Corporate Venturing
Biogen, Inc.: Partnership
Biogen, Inc.: Divestments
Biogen, Inc.: Recent Developments
Biogen, Inc.: News and Events Summary
Biogen, Inc.: Business Expansion
Biogen, Inc.: Contracts
Biogen, Inc.: Financial Deals
Biogen, Inc.: Financial Performance
Biogen, Inc.: Grants
Biogen, Inc.: Market Developments
Biogen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Locations and Subsidiaries
Table 4: Biogen, Inc.: Key Competitors
Table 5: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Biogen, Inc.: M&A Activity by Geography (TTM*)
Table 7: Biogen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Biogen, Inc.: Targets and Partners
Table 10: Biogen, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Biogen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Biogen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Biogen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Biogen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Biogen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Biogen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Biogen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Biogen, Inc.: News and Events Summary
Table 20: Biogen, Inc.: Business Expansion
Table 21: Biogen, Inc.: Contracts
Table 22: Biogen, Inc.: Financial Deals
Table 23: Biogen, Inc.: Financial Performance
Table 24: Biogen, Inc.: Grants
Table 25: Biogen, Inc.: Market Developments
Table 26: Biogen, Inc.: Strategy and Operations
List of Figures
Figure 1: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Biogen, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Biogen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Biogen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Biogen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Biogen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Biogen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Biogen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Biogen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report